ACADIA Pharmaceuticals Inc. (ACAD)
NASDAQ: ACAD · Real-Time Price · USD
14.75
-0.09 (-0.57%)
Apr 25, 2025, 11:14 AM EDT - Market open
ACADIA Pharmaceuticals Analyst Ratings
Total Analysts
16
Consensus Rating
Buy
Price Target
$23.93
Upside
+62.29%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Reiterates $28 | Strong Buy | Reiterates | $28 | +89.89% | Apr 8, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Initiates $20 | Hold | Initiates | $20 | +35.64% | Mar 7, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $28 | Buy | Reiterates | $28 | +89.89% | Feb 27, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $27 | Strong Buy | Reiterates | $27 | +83.11% | Feb 27, 2025 |
| Needham | Needham | Strong Buy Reiterates $28 | Strong Buy | Reiterates | $28 | +89.89% | Feb 27, 2025 |
| Deutsche Bank | Deutsche Bank | Hold Initiates $22 | Hold | Initiates | $22 | +49.20% | Feb 11, 2025 |
| Guggenheim | Guggenheim | Strong Buy → Hold Downgrades $20 | Strong Buy → Hold | Downgrades | $20 | +35.64% | Jan 3, 2025 |
| Needham | Needham | Strong Buy Reiterates $28 | Strong Buy | Reiterates | $28 | +89.89% | Nov 7, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $27 | Strong Buy | Reiterates | $27 | +83.11% | Nov 7, 2024 |
| Raymond James | Raymond James | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Oct 10, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $30 → $23 | Strong Buy | Maintains | $30 → $23 | +55.99% | Aug 8, 2024 |
| UBS | UBS | Strong Buy Maintains $25 → $23 | Strong Buy | Maintains | $25 → $23 | +55.99% | Aug 8, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $27 | Strong Buy | Reiterates | $27 | +83.11% | Aug 8, 2024 |
| Needham | Needham | Strong Buy Maintains $30 → $28 | Strong Buy | Maintains | $30 → $28 | +89.89% | Aug 7, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $37 → $28 | Buy | Maintains | $37 → $28 | +89.89% | Aug 7, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $29 → $26 | Buy | Maintains | $29 → $26 | +76.33% | Aug 7, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.